Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors

Background Thyroid immune-related adverse events (IRAEs) have been reported in patients treated with programmed cell death protein-1 (PD-1) and programmed cell death protein-ligand 1 (PD-L1) inhibitors. We investigated the incidence and clinical course of PD-1/PD-L1 inhibitor-induced thyroid IRAEs,...

Full description

Bibliographic Details
Main Authors: Jee Hee Yoon, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Format: Article
Language:English
Published: Academya Publishing Co. 2021-04-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://www.e-enm.org/upload/pdf/enm-2020-906.pdf

Similar Items